| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/AJG.2012.331 |
| P698 | PubMed publication ID | 23032979 |
| P2093 | author name string | Henry Lik-Yuen Chan | |
| Grace Lai-Hung Wong | |||
| Victor de Lédinghen | |||
| Vincent Wai-Sun Wong | |||
| Juliette Foucher | |||
| Julien Vergniol | |||
| Wassil Merrouche | |||
| Anthony Wing-Hung Chan | |||
| Paul Cheung-Lung Choi | |||
| Faiza Chermak | |||
| Shirley Ho-Ting Chu | |||
| Sophie Pesque | |||
| P433 | issue | 12 | |
| P921 | main subject | liver disease | Q929737 |
| metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
| fatty liver disease | Q6058862 | ||
| P304 | page(s) | 1862-1871 | |
| P577 | publication date | 2012-10-02 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease | |
| P478 | volume | 107 |
| Q58799831 | A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At-Risk Populations in Primary Care |
| Q86481064 | Appropriate use of virtual touch quantification and FibroScan M and XL probes according to the skin capsular distance |
| Q36156172 | Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update |
| Q50148381 | Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease |
| Q34036780 | Chronic permanent hypoxemia predisposes to mild elevation of liver stiffness |
| Q26852557 | Clinical Application of Transient Elastography in the Diagnosis of Liver Fibrosis: an Expert Panel Review and Opinion |
| Q26768262 | Clinical applications, limitations and future role of transient elastography in the management of liver disease |
| Q48234623 | Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods. |
| Q57782399 | Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan®: A Comparative Study with the M Probe and Liver Biopsy |
| Q91598061 | Controlled Attenuation Parameter for Assessment of Hepatic Steatosis in Indian Patients |
| Q37741824 | Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population |
| Q41456415 | Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography |
| Q35932326 | Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score |
| Q41706840 | Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease |
| Q56343202 | Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis |
| Q58713138 | Diagnostic accuracy of point shear wave elastography and transient elastography for staging hepatic fibrosis in patients with non-alcoholic fatty liver disease: a meta-analysis |
| Q55497819 | EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease. |
| Q60462090 | EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease |
| Q37149657 | Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre study |
| Q30398914 | Evaluation of Transient Elastography, Acoustic Radiation Force Impulse Imaging (ARFI), and Enhanced Liver Function (ELF) Score for Detection of Fibrosis in Morbidly Obese Patients |
| Q57128381 | Feasibility and Efficacy of Transient Elastography using the XL probe to diagnose liver fibrosis and cirrhosis: A meta-analysis |
| Q38790052 | Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016. |
| Q30395051 | Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations |
| Q89899473 | Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy |
| Q37257281 | Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease. |
| Q51161258 | Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values. |
| Q91656658 | In search of new biomarkers for nonalcoholic fatty liver disease |
| Q38859235 | JSUM ultrasound elastography practice guidelines: liver |
| Q90149236 | Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions! |
| Q57818077 | Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations |
| Q30448132 | Liver elastography, comments on EFSUMB elastography guidelines 2013. |
| Q26777511 | Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact |
| Q26780252 | Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance. |
| Q47942345 | Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy |
| Q40444861 | Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease |
| Q89123381 | Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants |
| Q30364476 | Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study. |
| Q30418856 | Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study |
| Q39170830 | Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD). |
| Q92521100 | Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness |
| Q39251875 | Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. |
| Q89074070 | Non-alcoholic fatty liver disease and the interface between primary and secondary care |
| Q38932554 | Non-alcoholic fatty liver disease in 2016. |
| Q30441653 | Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy |
| Q30423320 | Non-invasive diagnosis of advanced fibrosis and cirrhosis |
| Q30414504 | Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease |
| Q30366569 | Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE. |
| Q91824073 | Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis |
| Q38430909 | Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms |
| Q30238933 | Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic |
| Q28082686 | Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease |
| Q30355082 | Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease. |
| Q57173225 | Noninvasive biomarkers in NAFLD and NASH - current progress and future promise |
| Q38141711 | Noninvasive evaluation of NAFLD. |
| Q64068370 | Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice |
| Q49788920 | Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD. |
| Q30249400 | Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis |
| Q53265078 | Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea. |
| Q30366572 | Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study. |
| Q61447186 | Optimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting |
| Q45942296 | Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. |
| Q45066338 | Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease |
| Q26777483 | Personalized management of cirrhosis by non-invasive tests of liver fibrosis |
| Q45711780 | Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) - an 11-Year Prospective Study. |
| Q90862928 | Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease |
| Q52692830 | Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions. |
| Q64074380 | Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease |
| Q64997917 | Rational arrangement of measuring shear wave speed in the liver. |
| Q57170235 | Recent research trends and updates on nonalcoholic fatty liver disease |
| Q87637825 | Reply |
| Q46476704 | Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions |
| Q92999616 | Serial transient elastography examinations to monitor patients with type 2 diabetes: A prospective cohort study |
| Q61882116 | The Diagnostic Accuracy of Transient Elastography for the Diagnosis of Liver Fibrosis in Bariatric Surgery Candidates with Suspected NAFLD |
| Q64968668 | The Largest American Study Comparing Transient Elastography and the Aminotransferase-to-platelet Ratio Index Score, Two Noninvasive Tests for Liver Fibrosis Staging in HIV/HCV Coinfected Patients. |
| Q36880302 | The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease |
| Q34047077 | The frequency and determinants of liver stiffness measurement failure: a retrospective study of "real-life" 38,464 examinations |
| Q28079445 | Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? |
| Q30374820 | Transient elastography in clinical detection of liver cirrhosis: A systematic review and meta-analysis. |
| Q30454363 | Transient elastography: Kill two birds with one stone? |
| Q38359165 | Ultrasound elastography: liver |
| Q37615606 | Update of liver fibrosis and steatosis with transient elastography (Fibroscan). |
| Q38916843 | Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV. |
| Q38180992 | Utilization of FibroScan in clinical practice |
| Q70886743 | Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease |
| Q41392739 | WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver |
Search more.